CASI Pharmaceuticals Inc (CASI)
2.795
+0.12
(+4.29%)
USD |
NASDAQ |
May 03, 16:00
2.79
0.00 (0.00%)
After-Hours: 20:00
CASI Pharmaceuticals Net Income (Quarterly): -6.055M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.055M |
| September 30, 2023 | -4.635M |
| June 30, 2023 | -10.24M |
| March 31, 2023 | -6.009M |
| December 31, 2022 | -19.54M |
| September 30, 2022 | -5.201M |
| June 30, 2022 | -7.68M |
| March 31, 2022 | -8.596M |
| December 31, 2021 | -5.601M |
| September 30, 2021 | -10.22M |
| June 30, 2021 | -6.946M |
| March 31, 2021 | -13.88M |
| December 31, 2020 | -14.20M |
| September 30, 2020 | -16.95M |
| June 30, 2020 | -8.694M |
| March 31, 2020 | -8.441M |
| December 31, 2019 | -12.49M |
| September 30, 2019 | -9.891M |
| June 30, 2019 | -15.47M |
| March 31, 2019 | -8.177M |
| December 31, 2018 | -9.264M |
| September 30, 2018 | -8.756M |
| June 30, 2018 | -5.860M |
| March 31, 2018 | -3.591M |
| December 31, 2017 | -5.048M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.614M |
| June 30, 2017 | -2.409M |
| March 31, 2017 | -1.700M |
| December 31, 2016 | -2.674M |
| September 30, 2016 | -1.694M |
| June 30, 2016 | -3.292M |
| March 31, 2016 | -1.794M |
| December 31, 2015 | -1.703M |
| September 30, 2015 | -1.605M |
| June 30, 2015 | -2.096M |
| March 31, 2015 | -1.803M |
| December 31, 2014 | -1.597M |
| September 30, 2014 | -21.54M |
| June 30, 2014 | -1.616M |
| March 31, 2014 | -1.451M |
| December 31, 2013 | -1.308M |
| September 30, 2013 | -1.442M |
| June 30, 2013 | -1.852M |
| March 31, 2013 | -1.136M |
| December 31, 2012 | -0.3604M |
| September 30, 2012 | -1.188M |
| June 30, 2012 | -10.46M |
| March 31, 2012 | -2.534M |
| December 31, 2011 | 1.004M |
| September 30, 2011 | -1.308M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-19.54M
Minimum
Dec 2022
-4.635M
Maximum
Sep 2023
-10.04M
Average
-8.694M
Median
Jun 2020
Net Income (Quarterly) Benchmarks
| China Pharma Holding Inc | -1.232M |
| BIMI International Medical Inc | -3.129M |
| Linike Medical Group Ltd | -0.0104M |
| China Health Industries Holdings Inc | -0.4456M |
| Meihua International Medical Technologies Co Ltd | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.874M |
| Total Expenses (Quarterly) | 10.33M |
| EPS Diluted (Quarterly) | -0.46 |
| Enterprise Value | 25.58M |
| Gross Profit Margin (Quarterly) | 59.05% |
| Profit Margin (Quarterly) | -88.09% |
| Earnings Yield | -72.63% |
| Normalized Earnings Yield | -66.28 |